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Introduction
Evaluation of the extension and resectability of lesions is the main goal in liver and pancreas surgery. The sensitivity of pre-operative imaging studies has improved up to 60e75% with spiral CT and 80e85% with MR [1] , but the combination of diagnostic laparoscopy and intra-operative ultrasound (LIOUS) has achieved 90e96% accuracy in the staging of liver and pancreatic malignancies. This allows patients who are not candidates for curative surgery to be spared the ordeal of laparotomy [2e4] .
According to previous studies, intra-operative sonographic evaluation of abdominal malignancies provides additional information in 30e60% of the cases, and this information results in modification of the surgical strategy in 30e50% [5] . Adding ultrasound to the laparoscopic exploration of the abdominal cavity eliminates the main limitations of laparoscopy, which are:
-underestimation of portal vein and regional lymph node involvement; -low sensitivity in the detection of liver metastases. The purpose of this study was to evaluate the effectiveness of laparoscopic and open intra-operative ultrasound on surgical decision making and the staging of hepatic malignancies and benign or malignant pancreatic disease.
Materials and methods
In the years 2005e2008, 45 patients (aged 42e75 years) were selected for resective liver surgery and 48 others (aged 14e72 years) were selected for partial pancreatic resection at the General and Laparoscopic Surgical Dept. of the Monaldi Hospital in Naples, Italy. All the liver resections were for malignancies. The same was true for most of the pancreatic resections; 11 out of 48 (22.9%) were performed for benign pancreatic lesions (nodular or cystic).
All patients had been examined pre-operatively with biphasic contrast-enhanced spiral CT and trans-abdominal ultrasound. Laparoscopic ultrasonography (LIOUS) was done in all the cases. An Aloka SSD-5500 scanner (Aloka, Tokyo, Japan) was used with a flexible-tip, lateral-view multifrequency probe measuring 10 mm in diameter. When laparotomy was performed, intra-operative ultrasound (IOUS) was repeated with an electronic T-shaped linear probe.
Both probes have frequency ranges of 5e10 MHz. The probes were sterilized with hydrogen peroxide (STERRAD*), and no cover was utilized intra-operatively.
Results
In 6 of the 45 patients with liver tumors (13.3%), LIOUS revealed previously undetected bilobar intra-parenchymal nodes, which precluded curative resection. The examination thus spared 6 patients the ordeal of a useless laparotomy. In 5 other patients (11.1%), it provided information that changed the surgical strategy to include larger resections or additional segmentectomies (Figs. 1e3). Ultrasound was also helpful in defining tumor-free resection margins. It revealed insufficient resection in 4 patients (10.2%). Four resections were completed laparoscopically (10.2%); all the others (89.7%) were performed via laparotomy after hepatic pedicle clamping. LIUOS and IOUS were found to be particularly effective in the detection of sub-glissonian secondary lesions (central and peripheral) and in differentiating primary lesions from the regenerative nodules of chronic hepatitis. Moreover, it accurately defined the relationships of the lesions to the main portal pedicles, hepatic veins, and vena cava, thus allowing us to predict which vessels would be sectioned or spared during parenchymal transection.
In the 48 patients with pancreatic disease, LIOUS excluded the possibility of curative resection in 7 cases (14.4%), because of mesenteric vein infiltration (4 patients, 8.3%) (Figs. 4,5) , involvement of the celiac or para-aortic nodes (2 patients, 4.1%), or liver micro-metastases (1 patient, 2.1%).
Ultrasound revealed the exact location of 8 cystic lesions and 3 benign endocrine nodules (insulinomas) (Fig. 6 ) and defined their elations to the Wirsung duct and splenic vessels. Five of the 8 cystic lesions were complex cystadenoma-like lesions (Figs. 7,8 ), which were subjected to ultrasound-guided aspiration of fluid for chemical and cytologic analysis. In this study, LIOUS and IOUS played essential roles in the selection of candidates for resective surgery and for planning the surgical approach. The information provided affected the surgical strategy in 11 of the patients with liver disease (24.4%) and 13 of those with pancreatic disease (27%).
Discussion
For over 20 years intra-operative ultrasonography has been considered a useful pre-requisite for liver surgery [6] . It has been shown to change the surgical strategy in 30e50% of patients with liver tumors [5] , and it reveals occult liver metastases in 5e10% of operations. Preliminary results with contrast-enhanced intra-operative ultrasound (CEUS) have shown that this approach is more effective for detecting small liver lesions. It provided information not obtainable with conventional intra-operative ultrasound and modified the course of surgery in 79% of patients undergoing resection for hepatocellular carcinoma [7] . In the detection of liver metastases, it attained 96.1% sensitivity vs. 81.5% with plain ultrasound [8] .
In another study, LIOUS identified 17% of all undetected HCC nodules in patients undergoing liver resection [9] and allowed 38% of patients with hepatic metastases to avoid needless surgery [10] . Laparotomy was avoided in 63% of patients with unresectable hepatocellular carcinomas [11] . LIOUS identified liver tumors not visible at laparoscopy in 33% of the patients and provided staging information that supplemented laparoscopic findings in 42% [12] .
Even with the most advanced imaging techniques (multiphase spiral CT, MRI, FDG-PET), approximately 30% of liver lesions< 2 cm are not visualized, and sensitivity is poor for nodules less than 1 cm in diameter [13] .
In a study conducted by Norton et al. [4] on patients with pancreatic and liver malignancies, laparoscopy with ultrasound ruled out the possibility of radical surgery in 44% of the patients.
As for pancreatic surgery, evaluation of mesenteric vein infiltration, involvement of lymph nodes in the hepatic pedicle and celiac area, and detection of intra-hepatic metastases continue to be major hurdles for pre-operative imaging. The sensitivity of contrast-enhanced multiphase CT for diagnosis of vein infiltration has been estimated to be as high as 92%, when diagnosis is based on the criteria of venous obliteration, tumor involvement of more than one half of the vein circumference, vein wall irregularity, or stenosis [14] .
With laparoscopic staging, the possibility of radical pancreatic resections was excluded in 24.3% and 26% of the patients in two studies [2, 15] . The addition of LIOUS excluded an additional 11.1% of the candidates and increased sensitivity to 100% [2] . Other authors [16] have reported evaluation of the resectability of pancreatic cancer with a sensitivity of 90% for CT, 77% for endoscopic ultrasound, and 78% for LIOUS. John [17] found that LIOUS provided information not provided by laparoscopy in 53% of the cases and changed the decision regarding tumor resectability in 25%.
Evaluation of complex cystic lesions, location of endocrine tumors, and investigation of the relations with blood vessels and the Wirsung duct are possible only with endoscopic [18] and laparoscopic or intra-operative ultrasound (96% localization sensitivity) [19] . These approaches are also used to guide intra-operative aspiration of cyst fluid for chemical analysis.
The purpose of our study was to evaluate the effectiveness of laparoscopy plus laparoscopic ultrasound in staging liver and pancreas malignancies before the selection of a surgical strategy.
All but 4 of the liver resections were performed via laparotomy. LIOUS played a fundamental role in 11 cases (24.4%) by re-defining the disease stage (6 patients) or (coupled with IOUS) modifying the extent of resection (5 patients). In all cases, ultrasound provided important clinical and anatomic information relevant to the radicality of resection and integrity of the remaining parenchyma.
As for the patients with pancreatic disease, LIOUS excluded the possibility of radical resection in 7 of the 37 cases with malignant lesions (14.4%) by revealing infiltration of the mesenteric vessels, involvement of celiac or aortic nodes, or the presence of liver metastases that had been missed on pre-operative imaging studies.
Three insulinomas were located with the laparoscopic probe (in the head, body and tail of the pancreas). Removal of the first required open duodeno-pancreatectomy; the other two nodules were resected laparoscopically with enucleation. The 8 cystic lesions included 3 that proved to be pseudocysts and were drained laparoscopically. The other 5 were serous or mucinous cystadenomas. Two of these were resected laparoscopically with caudal splenopancreatectomy, and the other three were enucleated from the pancreatic tissue. In one case LIOUS revealed adherence of the cystic wall to a portion of the Wirsung duct. The patient underwent a second operation for repair of a pancreatic fistula and creation of an open pancreaticojejunostomy. LIOUS played an essential role in surgical decision making in 13 patients (27%), but it gave important information in all cases.
Given the results of our experience, we believe that laparoscopy with the addition of ultrasound should be used increasingly in the pre-operative work-up of patients with liver tumors or pancreatic disease (benign or malignant). It can provide useful information for staging tumors, defining surgical anatomy, and making surgical decisions. 
